Latest News
Conference Coverage
Protocol helped identify hospitalized children at risk for VTE
SAN DIEGO – Children with hospital-acquired VTE tended to be more medically complex, a single-center study showed.
Conference Coverage
Warfarin dose capping avoided supratherapeutic INRs in hospitalized elderly
SAN DIEGO – Limiting the initial dose of warfarin to 2.5 mg or less for hospitalized patients aged 85 years and older led to significant...
Conference Coverage
Think about breast cancer surveillance for transgender patients
CHICAGO - In transgender men, breast cancer can occur years after mastectomy.
Conference Coverage
Most patients off transfusions after gene therapy for thalassemia
SALT LAKE CITY – As the vector copy number goes up, so does the likelihood of stopping transfusions.
Conference Coverage
Checkpoint inhibition less toxic than antiangiogenic therapy in NSCLC
ORLANDO – Checkpoint blockade associated with less combined direct and indirect toxicity, a systematic review and meta-analysis suggests.
Feature
Preprint publishing challenges the status quo in medicine
The lack of peer review speeds the pace of discovery, but it comes with risks.
Daily News Podcast
MDedge Daily News: Why low-calorie sucralose may fuel weight gain
And diabetes in the United States racks up a hefty health bill.
Conference Coverage
Combined PARP, checkpoint inhibitor regimens show ovarian cancer activity
Good responses were found in the first two reports on treatment of ovarian cancer patients with combined a PARP inhibitor and an immune checkpoint...
Feature
Could European data privacy rules cost you big?
Rules designed to strengthen record protection for European Union citizens take effect in May.
News
FDA expands indication for blinatumomab in treating ALL
FDA grants accelerated approval to treat patients with B-cell precursor ALL who are in remission but still have minimal residual disease.
Conference Coverage
Many VTE patients live in fear of the next event
An estimated 41% of patients who experience a VTE fear another clot often or almost all the time.